Related Experiment Video
Updated: Jun 10, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Warfarin dosing in patients with impaired kidney function.
Nita A Limdi1, Mohit A Limdi, Larisa Cavallari
1Department of Neurology, University of Alabama at Birmingham, AL 35294-0021, USA. nlimdi@uab.edu
Summary
Warfarin dosing needs adjustment in patients with kidney impairment. Reduced doses are required for moderate and severe kidney impairment, with significant reductions observed in both groups.
Area of Science:
- Pharmacology
- Nephrology
- Clinical Pharmacy
Background:
- Warfarin dosing in patients with kidney impairment lacks robust data.
- Kidney function significantly impacts warfarin metabolism and dosage requirements.
- Current practice often uses standard dosing despite potential risks.
Purpose of the Study:
- To determine the impact of kidney impairment on warfarin dose requirements.
- To provide evidence-based recommendations for warfarin dosing in renal dysfunction.
- To identify factors influencing warfarin dose adjustments in patients with reduced kidney function.
Main Methods:
- Cross-sectional analysis of 980 long-term warfarin users.
- Categorization of kidney impairment based on estimated glomerular filtration rate (eGFR).
- Linear regression analysis to evaluate warfarin dose adjustments, controlling for clinical, demographic, and genetic factors.
Main Results:
- Prevalence of moderate and severe kidney impairment was significant in the study cohorts.
- Warfarin dose requirements were significantly lower in patients with moderate and severe kidney impairment.
- Moderate impairment led to a 9.5% dose reduction, while severe impairment required a 19% reduction.
Conclusions:
- Moderate and severe kidney impairment are associated with reduced warfarin dose requirements.
- Clinical guidelines should incorporate specific warfarin dosing adjustments for varying degrees of kidney impairment.
- Further research is needed to validate these findings and explore other biomarkers.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...